Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A0LTZ0

Entry ID Method Resolution Chain Position Source
AF-A0LTZ0-F1 Predicted AlphaFoldDB

No variants for A0LTZ0

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A0LTZ0

No associated diseases with A0LTZ0

No regional properties for A0LTZ0

Type Name Position InterPro Accession
No domain, repeats, and functional sites for A0LTZ0

Functions

Description
EC Number 2.5.1.141 Transferring alkyl or aryl groups, other than methyl groups
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
protoheme IX farnesyltransferase activity Catalysis of the reaction: protoheme IX + (2E,6E)-farnesyl diphosphate + H2O = heme O + diphosphate.

1 GO annotations of biological process

Name Definition
heme O biosynthetic process The chemical reactions and pathways resulting in the formation of heme O, a derivative of heme containing a 17-carbon hydroxyethylfarnesyl side chain at position 8 of the tetrapyrrole macrocycle.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MTALAPSSTP LPAGRRGAVD IVKGLIALTK PRIIELLLVT TVPTMMLAAR GWPSSRLVVV
70 80 90 100 110 120
TVLAGALAAG SANTLNCFID RDIDQVMRRT ARRPLVRSVI RPAEALAFGV ALGVVATLLM
130 140 150 160 170 180
GFLVNWLSAI LADAAIVFYV GVYTIGLKRR TPSNIVIGGA AGCFPVLIGW SAVTGRVGWP
190 200 210 220 230 240
AVVLFAVIFA WTPPHFWALA MRFREDYAAA HVPMLPVVAE PLVVARQILW YSYGMVAASL
250 260 270 280 290 300
ALAPVAHVGW VYVAIAALLG GWFLAEAHRI VQRVRLGRDP RPMRLFHMSI SYLTLLFVAV
ALAPYLP